Advertisement
News
Advertisement

Physicians Cite Positive First Clinical Experience with Volcano's Eagle Eye® Platinum Digital IVUS Catheter

Thu, 05/20/2010 - 7:37am
Bio-Medicine.Org

SAN DIEGO, May 20 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC) announced today the completion of the first clinical cases using the new Eagle Eye® Platinum digital IVUS catheter. The procedures were performed in seven centers within the United States. Commercial launch of Eagle Eye® Platinum in the U.S. is expected in June 2010.

(Photo: http://www.newscom.com/cgi-bin/prnh/20100520/SF08130)

"Our customer research of the most important IVUS catheter features found that both improved deliverability and the ability to easily estimate lesion length were vital," commented David Sheehan, President of Volcano's IVUS and Physiology Business Units. "We designed the Eagle Eye® Platinum to directly meet those needs. Deliverability was addressed with a more tapered tip, smoother design, and proprietary new GlyDx™ hydrophilic coating. The overwhelming response in clinical use thus far is that there is a remarkable difference physicians can feel, even through stents and challenging lesions. Plus, the three new radiopaque markers provide instant information, facilitating a more precise lesion length estimate, right on the angiogram."

After conducting one of the first clinical cases with Eagle Eye® Platinum, Dr. Craig Thompson, Associate Professor of Internal Medicine/Cardiology at Yale-New Haven Ho

'/>"/>

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading